Related Experiment Video
Updated: Jun 5, 2026
08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
Islet cell autoantigens in insulin-dependent diabetes
1Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville 32610.
The Journal of Clinical Investigation
|October 1, 1993
Summary
Identifying islet cell autoantigens in insulin-dependent diabetes (IDD) enhances disease predictability. The reactivity of native autoantigens suggests primary immunizing agents play a key role in IDD pathogenesis.
Area of Science:
- Immunology
- Endocrinology
- Pathogenesis of Autoimmune Diseases
Background:
- Insulin-dependent diabetes (IDD) involves autoimmunity against islet cells.
- Numerous islet cell autoantigens have been identified, with more anticipated.
Purpose of the Study:
- To explore the role of identified islet cell autoantigens in IDD pathogenesis.
- To investigate the significance of native autoantigen recognition in IDD development.
Main Methods:
- Analysis of identified islet cell autoantigens.
- Evaluation of autoantigen reactivity in native configurations.
- Correlation of autoantigen expression with islet cell activity and disease progression.
Main Results:
- Only two autoantigens (64 kD/GAD, 38 kD) show reactivity in their native forms, suggesting conformational epitope recognition is crucial.
- Islet cell activity levels may influence autoantigen expression and insulitis severity.
- Disparities in HLA associations may relate to autoantigen recognition differences.
Conclusions:
- Identification of islet cell autoantigens significantly aids IDD predictability and intervention strategies.
- Understanding autoantigen importance is key to elucidating IDD pathogenesis.
- The role of native antigen recognition points towards primary immunizing events in IDD.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...